The Effect of Music Meditation Therapy in Patients With Chronic Pain Receiving Botox
NCT03532607 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98
Last updated 2019-10-23
Summary
The purpose of this pilot study is to examine the impact of music meditation therapy session on patients with chronic pain who are receiving Botox injections at a pain management center.
Conditions
Interventions
- OTHER
-
Music
Patients will listen to soothing music for 30 minutes before their standard of care botox injection
Sponsors & Collaborators
-
Rowan University
lead OTHER
Principal Investigators
-
Richard Jermyn, DO · Rowan University School of Osteopathic Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-31
- Primary Completion
- 2020-04-30
- Completion
- 2020-04-30
Countries
- United States
Study Locations
More Related Trials
-
Subcutaneous Botulinum Toxin for Cutaneous Allodynia
NCT00725322 ·Status: COMPLETED ·Phase: NA
-
A Pilot Clinical Trial of Sympathetic Blockade With Botulinum Toxin Type A to Treat Complex Regional Pain Syndrome (CRPS): a Randomized, Double-Blind, Controlled, Crossover Trial.
NCT00637533 ·Status: COMPLETED ·Phase: NA
-
Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain
NCT01905137 ·Status: UNKNOWN ·Phase: NA
-
Botulinum Toxin for Chronic Neuropathic Pain
NCT06036043 ·Status: UNKNOWN
-
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
NCT02116361 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of OnabotulinumtoxinA (BOTOX®) on Stress
NCT06778421 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of the Effects of Botulinum Toxin in the Treatment of Provoked Vestibulodynia
NCT02858219 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study of Needle Size and Pain Perception With Botulinum Toxin A Injections
NCT01981174 ·Status: COMPLETED ·Phase: NA
-
Minimizing Pain During Office Intradetrussor Botox Injection
NCT04270526 ·Status: COMPLETED ·Phase: PHASE4
-
Botulinum Toxin Type A for Neuroma Pain
NCT01374191 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Treatment of Depression With Botulinum Type A Toxin
NCT01392963 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study to Assess the Efficacy of Botulinum Toxin A Treatments on Pain and Disability in Sub-Acute Low Back Pain
NCT00384371 ·Status: TERMINATED ·Phase: PHASE4
-
Pharmacodynamic and Safety of MEDITOXIN® in Healthy Male Volunteers
NCT03317717 ·Status: COMPLETED ·Phase: PHASE1
-
Subcutaneous Botulinum Toxin for Cutaneous Allodynia - Enriched Responder Trial
NCT00822926 ·Status: TERMINATED ·Phase: NA
-
Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A
NCT05720065 ·Status: RECRUITING ·Phase: PHASE2
-
BTA vs Baclofen for Pelvic Myofascial Pain Syndrome
NCT05617118 ·Status: UNKNOWN
-
Botulinum Toxin in Peripheral Neuropathic Pain
NCT01251211 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacodynamic and Safety of MT10107(Botulinum Type A Neurotoxin) in Comparison to BOTOX®
NCT03796351 ·Status: COMPLETED ·Phase: PHASE1
-
Botulinum Toxin to Treat Restless Legs Syndrome
NCT00479154 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Botulinum Toxin for Pelvic Pain in Women With Endometriosis
NCT01553201 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Intra-dermal Injection of Botulinum Toxin Type A for the Diabetic Neuropathic Foot Pain
NCT00336349 ·Status: COMPLETED ·Phase: NA
-
A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction
NCT06161246 ·Status: COMPLETED ·Phase: PHASE4
-
New Approaches in Evaluating Patients' Response to Botulinum Toxins in the Treatment of Chronic Neck Pain and Back Pain
NCT02008136 ·Status: UNKNOWN ·Phase: PHASE1
-
Are Paraspinous Intramuscular Injections of Botulinum Toxin A (BoNT-A) Efficient in the Treatment of Chronic Low-back Pain (LBP)?
NCT03181802 ·Status: COMPLETED ·Phase: PHASE3
-
Qualitative Study Patient & Physician Experiences Botox COVID-19
NCT05435404 ·Status: COMPLETED